Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2025-04-24 Director's Dealing
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2025-04-24 English
FORM 4
Director's Dealing
2025-04-24 English
FORM 4
Director's Dealing
2025-04-24 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on changes in senior management, specifically the departure of an Interim CEO and CFO, appointment of a new Interim CFO, and related severance and consulting agreements. There are no financial statements or detailed financial results presented, nor is this an earnings release or annual/interim report. The primary subject is management changes and related arrangements. Therefore, the document fits the category of Board/Management Information (MANG). The document length (8287 characters) supports it being a full report rather than a brief announcement or certification. Hence, the classification is MANG with high confidence.
2025-04-18 English
FORM 8-K/A
Board/Management Information Classification · 100% confidence The document is a Form 8-K/A filed with the SEC, which is an amendment to a Current Report on Form 8-K. The content focuses on the appointment of a new Chief Executive Officer, including details about the executive's background, compensation, and related arrangements. The document amends a previous filing to correct an omission regarding the new CEO's board membership. There are no financial statements or comprehensive financial data presented. The primary subject is a change in senior management. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document is not a full annual or quarterly report, nor is it an earnings release or other financial report. Therefore, the correct classification is MANG with high confidence.
2025-04-18 English
ARS
Annual Report
2025-03-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.